Ocuphire Pharma, Inc.
USD1.17
-0.16 (-12.03%)
CEO
George Magrath
IPO Date
2005-11-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.33
Prev. Close
$1.33
Day Low
$1.07
Day High
$1.36
52W Low
$1.07
52W High
$3.40
Market Cap
$0.03B
Volume
0.68M
| -0.6 |
| 31 Dec 2023 | FY | 100.0% | -52.4% | -20.0% | -18.5% | 0.00 | 13.35 | -2.8 |
| 31 Dec 2022 | FY | 100.0% | 44.9% | 38.7% | 36.5% | 0.00 | 17.79 | 1.4 |
| 31 Dec 2021 | FY | 100.0% | -9625.3% | -255.1% | -217.4% | 0.02 | 6.76 | -0.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 182.8% | -139.2% | 0.00 | 5.55 | -0.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 81.6% | -345.8% | -0.75 | 0.19 | -1.5 |
| -18.9 |
| 30 Sept 2025 | Q3 | 100.0% | -566.9% | -292.5% | -48.3% | 0.18 | 1.23 | -1.7 |
| 30 Jun 2025 | Q2 | -109.0% | -257.5% | -42.5% | -19.2% | 0.06 | 1.90 | -2.0 |
| 31 Mar 2025 | Q1 | 100.0% | -187.5% | -161.5% | -17.0% | 0.00 | 1.98 | -1.0 |
| 31 Dec 2024 | Q4 | -80.8% | -816.7% | -522.5% | -95.3% | 0.00 | 3.24 | -0.3 |
| 30 Sept 2024 | Q3 | 100.0% | -194.6% | -21.9% | -18.6% | 0.00 | 6.63 | -1.1 |
| 30 Jun 2024 | Q2 | 100.0% | -698.3% | -19.1% | -17.3% | 0.00 | 10.68 | -1.1 |
| 31 Mar 2024 | Q1 | 100.0% | -415.3% | -15.4% | -13.7% | 0.00 | 8.96 | -1.1 |
| 31 Dec 2023 | Q4 | -177.8% | -283.6% | -9.6% | -8.9% | 0.00 | 13.35 | -1.4 |